参考文献/References:
[1] Pinzone M R, Di R M, Cacopardo B, et al. HIV RNA suppression and immune restoration: can we do better?[J]. Clinical and Developmental Immunology, 2012, 2012: 515962.
[2] Montaner J S G, Lima V D, Harrigan P R, et al. Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting[J]. PLOS ONE, 2014, 9(2): e87872.
[3] Engsig F, Gerstoft J, Kronborg G, et al. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study[J]. BMC Infectious Dseases, 2010, 10: 318.
[4] Acheco Y M, Jarrin I, Rosado I, et al. Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort[J]. Antiviral Research, 2015, 117: 69-74.
[5] Gaardbo J C, Hartling H J, Gerstoft J, et al. Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions[J]. Clinical and Developmental Immunlogy, 2012, 183(9): 1328-1335.
[6] Onwumeh J, Okwundu C I, Kredo T, et al. Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults[J]. CEochrane Database of Systematic Reviews, 2017, 5: CD009818.
[7] Thiebaut R, Jarne A, Routy J P, et al. Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies[J]. Clincal Infectious Diseases, 2016, 62(9): 1178-1185.
[8] Gharakhanian S, Katlama C, Launey O, et al. VAC-3S, an Immunoprotective HIV Vaccine Directed to the 3S Motif of gp41, in Patients Receiving ART: Safety, Dose and Immunization Schedule Assessment[J]. AIDS Reaearch and Human Retrpvoruses, 2013, 29(11): A156-A156.
[9] 杨巧丽,郑好飞,刘颖. 温肾法与艾滋病中晚期患者的免疫重建[J]. 中医杂志,2016,57(18): 1614-1615.
[10] 王丹妮,陈秀敏,蒋自强,等. 湿邪与艾滋病免疫功能低下的相关性探讨[J]. 中华中医药杂志,2012,27(12): 3038-3040.
[11] 中华中医药学会防治艾滋病分会. 艾滋病免疫功能重建不良中西医协同治疗专家共识[J]. 中医学报,2020,35(2): 281-284.
[12] Li T, Xie J, Li Y, et al. Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety[J]. HIV Clinical Trials, 2015, 16(2): 49-56.
[13] 张绿浪,陈思源,邓长刚,等. 雷公藤治疗对艾滋病患者CD4+T淋巴细胞及炎症因子水平的影响[J]. 川北医学院学报,2018,33(5): 748-751.
[14] 陆鹏,莫让辉,梁柱石. 黄芪对免疫无应答艾滋病患者CD4+T淋巴细胞数的影响[J]. 中华实验和临床感染病杂志,2014,8(2): 108-109.
[15] 刘震,王阶,林洪生,等. 中药免疫2号方对艾滋病患者免疫重建的研究[J]. 中国中药杂志,2013,38(15): 2458-2462.
[16] 王阶,林洪生,李勇,等. 免疫2号方对艾滋病免疫重建不全患者临床症状、体征的影响[J]. 中医杂志,2012,53(11): 923-926.
[17] 赵霞,谢正兰,李铁. 加用益气补肾方对艾滋病免疫重建不全患者免疫功能的影响[J]. 广西中医药,2014,37(3): 36-38.
[18] 赵权,罗向群,徐奎,等. 自拟健脾益气方联合HARRT促进脾虚湿盛证型免疫重建不良艾滋病患者免疫重建的临床研究[J]. 中华医学,2018,10(30): 102-105.
[19] 咸庆飞,刘颖,邹雯,等. 温肾健脾颗粒对HAART后免疫重建不全艾滋病患者T淋巴细胞亚群的作用研究[J]. 中国中医基础医学杂志,2019,25(10): 1391-1455.
[20] 杨玉琪,瞿广城,陆中云,等. 扶正抗毒丸联合HAART治疗艾滋病免疫重建不全的临床疗效分析[J]. 中医药导报,2020,26(10): 66-68.
[21] 苏琛,彭鑫,刘晶晶. 培元胶囊联合HAART对艾滋病免疫重建不良的临床观察[J]. 中国艾滋病性病,2020,26(1): 19-22.
[22] 毛宇湘,李宝印,路聚更,等. 中药配合艾灸治疗HIV/AIDS的临床研究[J]. 中医学报,2012,27(1): 1-3.
[23] 王庆雷,路聚更,李中堂,等. 艾灸结合中医药辨证论治对艾滋病中CD4的影响[J]. 中医药导报,2012,18(6): 57-58.
[24] 李璇,黄婷,文彬,等. 壮药穴位贴敷配合HAART对30例老年艾滋病免疫重建不良病人疗效分析[J]. 中国艾滋病性病,2020,26(7): 753-756.
[25] 汤艳莉,王阶,李勇,等. 艾滋病免疫重建不全患者Toll样受体信号传导通路改变及免疫2号方干预的影响[J]. 中华中医药杂志,2012,27(4): 789-793.
[26] 邹雯,王健,高建国,等. 益气健脾颗粒联合HAART治疗对艾滋病免疫无应答患者TLR4和TLR9的影响[J]. 中华中医药杂志,2019,34(9): 4426-4428.
[27] 邹雯,王健,刘颖,等. 中药联合HAART治疗对艾滋病免疫功能重建不全患者TLR相关基因mRNA水平的影响[J]. 中华中医药杂志,2017,32(12): 5672-5674.
[28] 朱海鹏,郑玉宝,曹焕焕,等. HAART治疗下HIV感染者Th17/Treg的平衡及其与T细胞增殖、活化的相关性研究[J]. 热带医学杂志,2014,14(7): 859-863.
[29] 张曼,芮宝玲,沈弢,等. 静脉吸毒HIV-1感染者Th17/Treg失衡与疾病进展及单核细胞活化水平的相关性研究[J]. 中国病毒病杂志,2013,3(5): 330-334.
[30] 陈昕,朱铭凤,周成鹏,等. 从Th17/Treg平衡探究中医两重外治法联合HAART对艾滋病免疫重建不良的影响[J]. 中国艾滋病性病,2019,25(8): 776-778.
相似文献/References:
[1]李瑞祥 陈斯宁.中医药对 COPD 大鼠模型作用机理的研究进展[J].大众科技,2014,16(05):95.
[2]廖咸硕.慢性乙型肝炎中医药治疗进展[J].大众科技,2014,16(10):124.
Progress in the treatment of chronic hepatitis B with traditional Chinese medicine[J].Popular Science & Technology,2014,16(3):124.
[3]李鹏程 韦艾凌 张永琴 唐秋媛.中医药调控肝癌血管生成的研究近况[J].大众科技,2014,16(11):136.
Research status on traditional Chinese medicine of angiogenesis inhepatocellular carcinoma[J].Popular Science & Technology,2014,16(3):136.
[4]万 媛.中医药协同治疗卒中后抑郁症的研究近况[J].大众科技,2014,16(12):98.
The recent clinical research of Chinese-western therapy on post-stroke depression[J].Popular Science & Technology,2014,16(3):98.
[5]杨 赟 梁爱武.中医药对慢性阻塞性肺疾病MMP-9、TIMP-1 影响的研究进展[J].大众科技,2015,15(02):78.
慢性阻塞性肺疾病;基质金属蛋白酶-9;金属蛋白酶组织抑制-1;气道重塑;中医药[J].Popular Science & Technology,2015,15(3):78.
[6]张艳娟,吴 光.中医药院校助力精准扶贫工作研究——以广西中医药大学定点扶贫为例[J].大众科技,2019,21(09):129.
Research on Targeted Poverty Alleviation Work in Colleges and Universities of Traditional Chinese Medicine ——Take Guangxi University of Traditional Chinese Medicine as an Example[J].Popular Science & Technology,2019,21(3):129.
[7]陈曹华 李沛桢 周华亮 马潍珩 刘汝专.中医药治疗腰椎间盘突出症术后残留症状的研究进展[J].大众科技,2022,24(06):112.
Research Status of Postoperative Residual Symptoms of Lumbar Intervertebral Disc Herniation Treated with Traditional Chinese Medicine[J].Popular Science & Technology,2022,24(3):112.
[8]桂雄斌 伏广虎.中医药治疗变应性鼻炎研究进展[J].大众科技,2018,20(06):61.
[9]韦卓 伍燕宏 郑景辉.血府逐瘀汤治疗心血管病的研究进展[J].大众科技,2018,20(06):63.
[10]兰鹏潘凤仙苏锦勋.脑卒中后肩手综合征的中医药外治法研究进展[J].大众科技,2018,20(06):71.
[11]刘振威 相惠君 赵晓芳.中医药干预HIV感染者肠道菌群失调的思路与方法[J].大众科技,2022,24(05):79.
Thoughts and Methods of Traditional Chinese Medicine Intervention on Intestinal Flora Imbalance of HIV Infected Persons[J].Popular Science & Technology,2022,24(3):79.